Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-19-058441

Sr VP/Chief Commercial Officer gave up 472 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cearnal Martin E Sr VP/Chief Commercial Officer 2019-11-26 Shares withheld for taxes −472 $4.93 $2,327 147,945 D
Loading xslF345X03/doc4.xml…